158 related articles for article (PubMed ID: 19816950)
1. Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer.
Li Y; Zeng H; Xu RH; Liu B; Li Z
Stem Cells; 2009 Dec; 27(12):3103-11. PubMed ID: 19816950
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer.
Zhang Z; Chen X; Chang X; Ye X; Li Y; Cui H
Int J Mol Med; 2013 Jan; 31(1):147-53. PubMed ID: 23174760
[TBL] [Abstract][Full Text] [Related]
3. Cancer therapy with major histocompatibility complex-deficient and interferon β-producing myeloid cells derived from allogeneic embryonic stem cells.
Umemoto S; Haruta M; Sakisaka M; Ikeda T; Tsukamoto H; Komohara Y; Takeya M; Nishimura Y; Senju S
Cancer Sci; 2019 Oct; 110(10):3027-3037. PubMed ID: 31348591
[TBL] [Abstract][Full Text] [Related]
4. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with human amniotic epithelial cells confer effective protection in a murine model of Colon adenocarcinoma.
Tabatabaei M; Mosaffa N; Ghods R; Nikoo S; Kazemnejad S; Khanmohammadi M; Mirzadegan E; Mahmoudi AR; Bolouri MR; Falak R; Keshavarzi B; Ramezani M; Zarnani AH
Int J Cancer; 2018 Apr; 142(7):1453-1466. PubMed ID: 29139122
[TBL] [Abstract][Full Text] [Related]
6. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
7. Therapy of peritoneally disseminated colon cancer by TAP-deficient embryonic stem cell-derived macrophages in allogeneic recipients.
Haga E; Endo Y; Haruta M; Koba C; Matsumura K; Takamatsu K; Ikeda T; Nishimura Y; Senju S
J Immunol; 2014 Aug; 193(4):2024-33. PubMed ID: 25031460
[TBL] [Abstract][Full Text] [Related]
8. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.
Zhao L; Teklemariam T; Hantash BM
Stem Cell Res; 2014 Sep; 13(2):342-54. PubMed ID: 25218797
[TBL] [Abstract][Full Text] [Related]
9. Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine.
Li Y; Yang F; Sang L; Zhu J; Han X; Shan F; Li S; Zhai J; Wang D; Lu C; Sun X
Oncol Rep; 2015 Oct; 34(4):1795-804. PubMed ID: 26238268
[TBL] [Abstract][Full Text] [Related]
10. A cytotoxic monoclonal antibody to colon adenocarcinoma.
Kaszubowski PA; Terasaki PI; Chia DS; Kukes GD; Hardiwidjaja SI; Cicciarelli JC
Cancer Res; 1984 Mar; 44(3):1194-9. PubMed ID: 6362858
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
[TBL] [Abstract][Full Text] [Related]
12. HOCl oxidation-modified CT26 cell vaccine inhibits colon tumor growth in a mouse model.
Zhou R; Huang WJ; Ma C; Zhou Y; Yao YQ; Wang YX; Gou LT; Yi C; Yang JL
Asian Pac J Cancer Prev; 2012; 13(8):4037-43. PubMed ID: 23098513
[TBL] [Abstract][Full Text] [Related]
13. Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer.
Kao JY; Zhang M; Chen CM; Chen JJ
Immunol Lett; 2005 Nov; 101(2):154-9. PubMed ID: 15993950
[TBL] [Abstract][Full Text] [Related]
14. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
Morita R; Hirohashi Y; Torigoe T; Ito-Inoda S; Takahashi A; Mariya T; Asanuma H; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Kutomi G; Mizuguchi T; Terui T; Ishitani K; Hashino S; Kondo T; Minagawa N; Takahashi N; Taketomi A; Todo S; Asaka M; Sato N
Clin Cancer Res; 2016 Jul; 22(13):3298-309. PubMed ID: 26861454
[TBL] [Abstract][Full Text] [Related]
15. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
[TBL] [Abstract][Full Text] [Related]
16. An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
Lupu CM; Eisenbach C; Kuefner MA; Schmidt J; Lupu AD; Stremmel W; Encke J
J Gastrointest Surg; 2006 May; 10(5):635-45. PubMed ID: 16713537
[TBL] [Abstract][Full Text] [Related]
17. The combined effect against colon-26 cells of heat treatment and immunization with heat treated colon-26 tumour cell extract.
Okamoto M; Tazawa K; Kawagoshi T; Maeda M; Honda T; Sakamoto T; Tsukada K
Int J Hyperthermia; 2000; 16(3):263-73. PubMed ID: 10830588
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.
Vo MC; Nguyen-Pham TN; Lee HJ; Jaya Lakshmi T; Yang S; Jung SH; Kim HJ; Lee JJ
Oncotarget; 2017 Apr; 8(16):27252-27262. PubMed ID: 28460478
[TBL] [Abstract][Full Text] [Related]
20. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
